Clinical Trial Update: Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the effectiveness and tolerability of OROS Hydromorphone for cancer pain in Korean patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• OROS Hydromorphone (hydromorphone)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Cancer Pain | Phase 4 | Status: COMPLETED